"Prostate cancer progression" trang 1 - tải miễn phí từ tailieunhanh
Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression
8    60    1
Ebook Prostate cancer: Biochemistry, molecular biology and genetics

Ebook Prostate cancer: Biochemistry, molecular biology and genetics
517    1    1
Ebook Prostate cancer: Biochemistry, molecular biology and genetics

Ebook Prostate cancer: Biochemistry, molecular biology and genetics
517    1    1
MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer
18    1    1
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion

Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion
15    52    1
Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
12    42    1
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
7    48    1
Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone

Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone
9    47    1
Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy
9    60    1
Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model

Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model
14    1    1
CKAP2L, a crucial target of miR-326, promotes prostate cancer progression

CKAP2L, a crucial target of miR-326, promotes prostate cancer progression
11    26    1
Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer

Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
11    23    1
Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer

Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
8    94    0
Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance

Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance
11    81    1
The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression

The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression
8    61    1
An agent-based model of prostate Cancer bone metastasis progression and response to Radium223

An agent-based model of prostate Cancer bone metastasis progression and response to Radium223
19    50    1
UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression
8    29    1
Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate cancer predict prostatic disease progression

Altered staining patterns and expression level of Engrailed-2 in benign prostatic hyperplasia and prostate cancer predict prostatic disease progression
13    36    1
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
10    49    1
Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy
9    65    1